EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reservoir‐Type Subcutaneous Implantable Devices Containing Porous Rate Controlling Membranes for Sustained Delivery of Risperidone

Linlin Li, Andi Dian Permana, Juan Domínguez-Robles, Muh Nur Amir, Habibie Habibie, Qonita Kurnia Anjani, Li Zhao, Natalia Moreno-Castellanos, Ryan F Donnelly, Eneko Larrañeta iD

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202403689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Linlin Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Queen's University Belfast, Lisburn Road 97, Belfast, BT9 7BL, UK. Hauptthemen laut MEDLINE: Drug Implants, Risperidone, Delayed-Action Preparations, Polyesters. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Sevilla, Ministerio de Ciencia e Innovación, Engineering and Physical Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Implantable drug delivery systems are crucial for achieving sustained delivery of active compounds to specific sites or systemic circulation. In this study, a novel reservoir‐type implant combining a biodegradable rate‐controlling membrane with a drug‐containing core prepared using direct compression techniques is developed. The membrane is composed of poly(caprolactone) (PCL), and risperidone (RIS) served as the model drug. Characterization of both membranes and direct compressed pellets includes hardness testing, optical coherence tomography, mercury intrusion porosimetry, and surface morphology observation. In vitro release studies of RIS reveal that higher drug loading in the pellets extended‐release duration up to 70 days when incorporated into membranes with four layers. Increasing the number of membrane layers slows the release rate further, ranging from 70 to 170 days depending on membrane thickness. Biocompatibility studies demonstrate that these implantable devices are non‐toxic and biocompatible with cells in vitro. In vivo studies conduct in male Wistar rats demonstrate sustained release of RIS, with plasma levels showing a significant increase post‐implantation at a relatively constant rate for up to 49 days. These results indicate that the developed implants have the potential to provide long‐acting drug delivery to the systemic circulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug ImplantsRisperidoneDelayed-Action PreparationsPolyestersMembranes, ArtificialPorosityDrug LiberationSurface PropertiesDrug CompoundingRats, WistarMaleAnimalsRatsMaterials TestingAntipsychotic AgentsHumansCells, Cultured

Stichwörter der Autor:innen

Implantable devicespoly(caprolactone)porous membranesrisperidonesustained delivery

Substanzen

Drug ImplantsRisperidoneDelayed-Action PreparationsMembranes, ArtificialpolycaprolactonePolyestersAntipsychotic Agents

Autor:innen und Institutionen

  • School of Pharmacy, Queen's University Belfast, Lisburn Road 97, Belfast, BT9 7BL, UK.
  • Faculty of Pharmacy, Hasanuddin University, Makassar, 90245, Indonesia.
  • Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Seville, Seville, 41012, Spain.
  • CICTA, Department of Basic Sciences, Medicine School, Health Faculty, Universidad Industrial de Santander, Cra 27 calle 9, Bucaramanga, 680002, Colombia.

ORCID-Profile: Eneko Larrañeta

Förderung

  • Universidad de Sevilla
  • Ministerio de Ciencia e Innovación
  • Engineering and Physical Sciences Research Council
  • Academy of Medical Sciences

Zitieren

APA

Li, L., Permana, A. D., Domínguez-Robles, J., Amir, M. N., Habibie, H., Anjani, Q. K., Zhao, L., Moreno-Castellanos, N., Donnelly, R. F., & Larrañeta, E. (2025). Reservoir‐Type Subcutaneous Implantable Devices Containing Porous Rate Controlling Membranes for Sustained Delivery of Risperidone. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202403689

Vancouver

Li L, Permana AD, Domínguez-Robles J, Amir MN, Habibie H, Anjani QK, et al. Reservoir‐Type Subcutaneous Implantable Devices Containing Porous Rate Controlling Membranes for Sustained Delivery of Risperidone. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202403689

BibTeX
@article{Li2025,
  author = {Li, Linlin and Permana, Andi Dian and Domínguez-Robles, Juan and Amir, Muh Nur and Habibie, Habibie and Anjani, Qonita Kurnia and Zhao, Li and Moreno-Castellanos, Natalia and Donnelly, Ryan F and Larrañeta, Eneko},
  title = {Reservoir‐Type Subcutaneous Implantable Devices Containing Porous Rate Controlling Membranes for Sustained Delivery of Risperidone},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202403689}
}
Kostenlos starten →